Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Acknowledgments The authors thank Prof
Our crowd favorite
The LEADER trial provided landmark evidence that liraglutide reduces cardiovascular death and major adverse cardiovascular events in patients with type 2 diabetes
[oai_citation:6PubMed]( [oai_citation:7PMC]( 5) Gastroprotective/cytoprotective actions in rodent models Multiple rat studies describe protection/healing in NSAID-induced and other gastric ulcer paradigms, consistent with mucosal cytoprotection concepts
US$ 26.61
US$ 22.65
US$ 24.14
US$ 23.29
US$ 27.63
